Resources

Type of publications
Regions
Diseases
4906 results found
2022 ∙ Ngangue, P. Pilabré, A. H. Barro, A. Pafadnam, Y. Bationo, N. Soubeiga, D.
Public attitudes towards COVID-19 vaccines in Africa: A systematic review
Africa Adults Healthcare workers COVID-19 Acceptance
Rating:
Not applicable
2022 ∙ Mannocci, A. Pellacchia, A. Millevolte, R. Chiavarini, M. de Waure, C.
Quadrivalent Vaccines for the Immunization of Adults against Influenza: A Systematic Review of Randomized Controlled Trials
Adults Influenza Efficacy/effectiveness Administration
Rating:
Critically low
2022 ∙ Ng, S. M. Pan, J. Mouyis, K. Kondapally Seshasai, S. R. Kapil, V. Rice, K. M. Gupta, A. K.
Quantifying the Excess Risk of Adverse COVID-19 Outcomes in Unvaccinated Individuals With Diabetes Mellitus, Hypertension, Ischaemic Heart Disease or Myocardial Injury: A Meta-Analysis
Adults Low and Middle Income Countries COVID-19 Safety
Rating:
Low
2022 ∙ Oueijan, R. I. Hill, O. R. Ahiawodzi, P. D. Fasinu, P. S. Thompson, D. K.
Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review
Adolescents Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Nguyen, T. T. Quach, T. H. T. Tran, T. M. Phuoc, H. N. Nguyen, H. T. Vo, T. K. Vo, G. V.
Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
Adults COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Critically low
2022 ∙ Wang, K. Wang, L. Li, M. Xie, B. He, L. Wang, M. Zhang, R. Hou, N. Zhang, Y. Jia, F.
Real-Word Effectiveness of Global COVID-19 Vaccines Against SARS-CoV-2 Variants: A Systematic Review and Meta-Analysis
All age groups COVID-19 Administration Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Wang, W. Kothari, S. Baay, M. Garland, S. M. Giuliano, A. R. Nygard, M. Velicer, C. Tota, J. Sinha, A. Skufca, J. Verstraeten, T. Sundstrom, K.
Real-world impact and effectiveness assessment of the quadrivalent HPV vaccine: a systematic review of study designs and data sources
All age groups Human papillomavirus (HPV) Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Wang, W. V. Kothari, S. Skufca, J. Giuliano, A. R. Sundstrom, K. Nygard, M. Koro, C. Baay, M. Verstraeten, T. Luxembourg, A. Saah, A. J. Garland, S. M.
Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review
All age groups Human papillomavirus (HPV) Efficacy/effectiveness Administration
Rating:
Critically low
2022 ∙ Bencina, G. Costantino, C. Mameli, C. Sabale, U. Murtagh, J. Newman, R. Ahern, A. Bhaila, R. Sanchez, A. O. Martinon-Torres, F. Carias, C.
Real-world impact of rotavirus vaccination in European healthcare settings: a systematic literature review
Europe All age groups Rotavirus Coverage Economic aspects Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Périères, L. Séror, V. Boyer, S. Sokhna, C. Peretti-Watel, P.
Reasons given for non-vaccination and under-vaccination of children and adolescents in sub-Saharan Africa: A systematic review
Africa Newborn Children Adolescents Parents/caregivers Acceptance Coverage Economic aspects
Rating:
Not applicable
Loading...